References
1. Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus From Patients with
Pneumonia in China, 2019. N Engl J Med 382:727-733, 2020. doi:
10.1056/NEJMoa2001017.
2. Carod-Artal FJ. Post-COVID-19 Syndrome: Epidemiology, Diagnostic
Criteria and Pathogenic Mechanisms Involved. Rev Neurol 72:384-396.
English, Spanish, 2021 Jun 1. doi: 10.33588/rn.7211.2021230.
3. Tansey CM, Louie M, Loeb M, et al. One-year Outcomes and Health Care
Utilization in Survivors of Severe Acute Respiratory Syndrome. Arch
Intern Med 167:1312-1320, 2007. doi: 10.1001/archinte.167.12.1312.
4. Lam MH, Wing YK, Yu MW, et al. Mental Morbidities and Chronic Fatigue
in Severe Acute Respiratory Syndrome Survivors: Long-term
Follow-up. Arch Intern Med 169:2142-2147, 2009. doi:
10.1001/archinternmed.2009.384.
5. Baraniuk JN, Kern G, Narayan V, Cheema A. Exercise Modifies Glutamate
and Other Metabolic Biomarkers in Cerebrospinal Fluid from Gulf War
Illness and Myalgic Encephalomyelitis / Chronic Fatigue Syndrome. PLOS
ONE 16:e0244116, 2021 Jan 13. doi: 10.1371/journal.pone.0244116.
6. Bested AC, Marshall LM. Review of Myalgic Encephalomyelitis/Chronic
Fatigue Syndrome: An Evidence-based Approach to Diagnosis and Management
by Clinicians. Rev Environ Health 30:223-249, 2015. doi:
10.1515/reveh-2015-0026.
7. Committee on the Diagnostic Criteria for Myalgic
Encephalomyelitis/Chronic Fatigue Syndrome, Board on the Health of
Select Populations, Institute of Medicine. Beyond Myalgic
Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness.
National Academies Press, Washington (DC). (US), 2015 Feb 10. doi:
10.17226/19012.
8. Kuratsune H, Yamaguti K, Takahashi M, Misaki H, Tagawa S, Kitani T.
Acylcarnitine Deficiency in Chronic Fatigue Syndrome. Clin Infect Dis 18
Suppl 1:S62-S67, 1994 Jan. doi: 10.1093/clinids/18.supplement_1.s62.
9. Ladds E, Rushforth A, Wieringa S, et al. Persistent Symptoms After
COVID-19: Qualitative Study of 114 ‘Long COVID’ Patients and Draft
Quality Principles for Services. BMC Health Serv Res 20:1144, 2020. doi:
10.1186/s12913-020-06001-y.
10. Amsalem D, Dixon LB, Neria Y. The Coronavirus Disease 2019
(COVID-19) Outbreak and Mental Health: Current Risks and Recommended
Actions. JAMA Psychiatry 78:9-10, 2021. doi:
10.1001/jamapsychiatry.2020.1730.
11. Asprusten TT, Sulheim D, Fagermoen E, Winger A, Skovlund E, Wyller
VB. Systemic Exertion Intolerance Disease Diagnostic Criteria Applied on
an Adolescent Chronic Fatigue Syndrome Cohort: Evaluation of Subgroup
Differences and Prognostic Utility. BMJ Paediatr Open 2:e000233, 2018
Mar 16. doi: 10.1136/bmjpo-2017-000233.
12. White PD, Goldsmith KA, Johnson AL, et al. Comparison of Adaptive
Pacing Therapy, Cognitive Behaviour Therapy, Graded Exercise Therapy,
and Specialist Medical Care for Chronic Fatigue Syndrome (PACE): A
Randomised Trial. Lancet 377:823-836, 2011 Mar 5. doi:
10.1016/S0140-6736(11)60096-2.
13. Miwa S, Takikawa O. [Chronic Fatigue Syndrome and
Neurotransmitters]. Nihon Rinsho 65:1005-1010. Japanese, 2007 Jun.
14. Jones MG, Goodwin CS, Amjad S, Chalmers RA. Plasma and Urinary
Carnitine and Acylcarnitine in Chronic Fatigue Syndrome. Clin Chim Acta
360:173-177, 2005 Oct. doi: 10.1016/j.cccn.2005.04.029.
15. Reuter SE, Evans AM. Long-chain Acylcarnitine Deficiency in Patients
with Chronic Fatigue Syndrome. Potential Involvement of Altered
Carnitine Palmitoyltransferase-I Activity. J Intern Med 270:76-84, 2011
Jul. doi: 10.1111/j.1365-2796.2010.02341.x.
16. Kuratsune H, Yamaguti K, Watanabe Y, et al. Acylcarnitine and
Chronic Fatigue Syndrome. in: Carnitine Today. De Simone C, Famularo G
Eds. RG Landes Company, Austin, 1997:195-213.
17. Piccoli C, Quarato G, Ripoli M, et al. HCV Infection Induces
Mitochondrial Bioenergetic Unbalance: Causes and Effects. Biochim
Biophys Acta 1787:539-546, 2009. doi: 10.1016/j.bbabio.2008.11.008.